Emergent BioSolutions Inc. (EBS) insider trading

By person

17 insiders · 1 transaction

3.3×

Joseph Papa holds only 3.3 times base salary in stock. $3.50M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph Papa last reported holding, valued at $7.09, the price Common Stock was last bought or sold at on the open market here, on 7 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Donald W DeGolyer

Director

—

$126.20K (1) scheduled

−$126.20K

111,921

0.2183%

$793.52K

−17.8%

Joseph C Papa

President and CEO

—

493,153

0.9618%

$3.50M

—

Richard S Lindahl

EVP, Chief Financial Officer

—

374,083

0.7296%

$2.65M

+118.8%

Coleen Glessner

EVP, Quality & Ethics, and CPL

—

202,201

0.3944%

$1.43M

+23.9%

William Hartzel

SVP, Bioservices

—

185,558

0.3619%

$1.32M

+285.7%

Simon C Lowry

SVP, R&D, CMO

—

177,914

0.3470%

$1.26M

—

Jessica Perl

SVP, General Counsel, Corp Sec

—

165,286

0.3224%

$1.17M

+2,329%

Neal Franklin Fowler

Director

—

160,847

0.3137%

$1.14M

+18.2%

Paul Anthony Williams

SVP, Products Business

—

156,098

0.3044%

$1.11M

+541.5%

Zsolt Harsanyi

Chairman

—

149,076

0.2907%

$1.06M

+66.9%

Louis W Sullivan

Director

—

139,098

0.2713%

$986.20K

+32.9%

Ronald Richard

Director

—

123,761

0.2414%

$877.47K

+74.0%

Marvin L White

Director

—

113,839

0.2220%

$807.12K

+66.5%

Sujata Tyagi Dayal

Director

—

100,563

0.1961%

$712.99K

+59.3%

Keith Katkin

Director

—

96,294

0.1878%

$682.72K

+60.8%

Kathryn C Zoon

Director

—

79,941

0.1559%

$566.78K

+46.7%

John D Fowler Jr

Director

—

30,350

0.0592%

$215.18K

—

Emergent BioSolutions Inc.

What the insiders did Scheduled selling only

By person